Related Experiment Videos
NovaSure impedance-controlled system for endometrial ablation.
Adolf Gallinat1, Wolfgang Nugent
1Tagesklinik Altonaer Strasse, Altonaer Strasse 59-61, Hamburg 20357, Germany.
Summary
The NovaSure endometrial ablation system effectively treats severe dysfunctional uterine bleeding (DUB) in women. This safe procedure requires no pretreatment and offers significant relief from menorrhagia.
Area of Science:
- Gynecology
- Minimally Invasive Surgery
Background:
- Dysfunctional uterine bleeding (DUB) significantly impacts women's quality of life.
- Medical therapies for DUB are often ineffective for severe cases.
Purpose of the Study:
- To evaluate the safety and efficacy of the NovaSure endometrial ablation system for severe DUB.
- To assess the NovaSure system's performance in women unresponsive to medical management.
Main Methods:
- A prospective, observational pilot study involving 107 premenopausal women with menorrhagia.
- Endometrial ablation performed using the NovaSure system without pretreatment.
- Follow-up included assessment of menstrual blood loss and bleeding patterns over 12 months.
Main Results:
- The NovaSure system demonstrated high safety with no intraoperative or postoperative complications.
- Significant amenorrhea rates observed: 46% at 6 months and 58% at 12 months.
- Average treatment time was 94 seconds.
Conclusions:
- The NovaSure system is a safe and effective treatment for women with DUB.
- Endometrial pretreatment is unnecessary for successful NovaSure ablation.
- The presence of blood in the uterine cavity does not impede treatment efficacy.